Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
99 hedge funds and large institutions have $321M invested in Gritstone bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 9 closing their positions.
322% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 9
155% more capital invested
Capital invested by funds: $126M → $321M (+$195M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
45% more call options, than puts
Call options by funds: $526K | Put options by funds: $363K
39% more funds holding
Funds holding: 71 → 99 (+28)
16% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 25
15.16% less ownership
Funds ownership: 84.71% → 69.55% (-15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$31.7M |
| 2 |
Morgan Stanley
New York
|
+$15M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$14M |
| 4 |
Millennium Management
New York
|
+$7.42M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$6.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Frazier Management
Seattle,
Washington
|
-$14.2M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$11.5M |
| 3 |
Blackstone Inc
New York
|
-$10.1M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$8.42M |
| 5 |
CG
Column Group
San Francisco,
California
|
-$3.43M |
GRTS Hedge Fund Activity: Q1 2021 in Review
99 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q1 2021, worth a combined $321M — up 155% from $126M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new GRTS positions and 9 closed out — a net gain of 29 holders — while 29 added to existing stakes and 25 trimmed.
The largest buyer was Palo Alto Investors, opening a new position worth an estimated $31.7M. The largest seller was Frazier Management, cutting an estimated $14.2M.
- 99 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q1 2021, up from 71 in Q4 2020.
- Funds reported $321M of Gritstone bio, Inc. Common Stock stock for Q1 2021, up 155% quarter-over-quarter.
- 38 funds opened new Gritstone bio, Inc. Common Stock positions in Q1 2021 and 9 closed out, a net change of +29 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q1 2021 was Palo Alto Investors, an estimated $31.7M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q1 2021 was Frazier Management, an estimated $14.2M sold.
Based on aggregated 13F filings for Q1 2021.